Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
- PMID: 8903320
- PMCID: PMC507645
- DOI: 10.1172/JCI119006
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
Abstract
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen which mediates its effects by binding to tyrosine kinase receptors. We have characterized the VEGF-activated intracellular signal transduction pathway in bovine aortic endothelial cells and correlated this to its mitogenic effects. VEGF induced concentration- and time-dependent increases in protein kinase C (PKC) activation with a maximum of 2.2-fold above the basal level at 5 x 10(-10) M within 10 min as measured both by in situ and translocation assays. Immunoblotting analysis of PKC isoforms in cytosolic and membrane fractions indicated that after VEGF stimulation the content of Ca(2+)-sensitive PKC isoforms (alpha and betaII) was increased in the membrane fractions, whereas no changes were observed for PKC isoforms delta and epsilon. The stimulation of PKC activity by VEGF was preceded by the activation of phospholipase Cgamma (PLCgamma). This was demonstrated by parallel increases in PLCgamma tyrosine phosphorylation, [3H]inositol phosphate production, and [3H]arachidonic acid-labeled diacylglycerol formation in bovine aortic endothelial cells. In addition, VEGF increased phosphatidylinositol 3-kinase activity 2.1-fold which was inhibited by wortmannin, a phosphatidylinositol 3-kinase inhibitor, without decreasing the VEGF-induced increase in PKC activity or endothelial cell growth. Interestingly, genistein, a tyrosine kinase inhibitor, and GFX or H-7, PKC inhibitors, abolished both VEGF-induced PKC activation and endothelial cell proliferation. VEGF's mitogenic effect was inhibited by a PKC isoform beta-selective inhibitor, LY333531, in a concentration-dependent manner. In contrast, antisense PKC-alpha oligonucleotides enhanced VEGF-stimulated cell growth with a simultaneous decrease of 70% in PKC-alpha protein content. Thus, VEGF appears to mediate its mitogenic effects partly through the activation of the PLCgamma and PKC pathway, involving predominately PKC-beta isoform activation in endothelial cells.
Similar articles
-
The proliferative effect of vascular endothelial growth factor requires protein kinase C-alpha and protein kinase C-zeta.Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):178-85. doi: 10.1161/01.atv.19.1.178. Arterioscler Thromb Vasc Biol. 1999. PMID: 9888881
-
Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway.Diabetes. 1999 May;48(5):1145-55. doi: 10.2337/diabetes.48.5.1145. Diabetes. 1999. PMID: 10331422
-
Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.Br J Pharmacol. 2001 Nov;134(6):1253-62. doi: 10.1038/sj.bjp.0704367. Br J Pharmacol. 2001. PMID: 11704645 Free PMC article.
-
Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes.Diabetologia. 2001 Jun;44(6):659-73. doi: 10.1007/s001250051675. Diabetologia. 2001. PMID: 11440359 Review.
-
Protein kinase C activation and its pharmacological inhibition in vascular disease.Vasc Med. 2000;5(3):173-85. doi: 10.1177/1358836X0000500307. Vasc Med. 2000. PMID: 11104300 Review.
Cited by
-
Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.Invest New Drugs. 2002 Aug;20(3):241-51. doi: 10.1023/a:1016297611825. Invest New Drugs. 2002. PMID: 12201487
-
Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):383-8. doi: 10.1073/pnas.012074399. Epub 2001 Dec 26. Proc Natl Acad Sci U S A. 2002. PMID: 11756651 Free PMC article.
-
Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E.Cancer Sci. 2003 Sep;94(9):751-6. doi: 10.1111/j.1349-7006.2003.tb01514.x. Cancer Sci. 2003. PMID: 12967471 Free PMC article. Review.
-
Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner.J Biol Chem. 1999 Jun 4;274(23):16349-54. doi: 10.1074/jbc.274.23.16349. J Biol Chem. 1999. PMID: 10347193 Free PMC article.
-
Molecular Tools for Metastatic Colorectal Cancer Characterization.J Cell Immunol. 2020;2(6):359-363. doi: 10.33696/immunology.2.067. J Cell Immunol. 2020. PMID: 33426543 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous